Trailing-twelve-month (TTM) revenue is $870.38 Million with a year-over-year growth of (2.71%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-08-31 | $209,189,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-09 |
| Q2 FY2026Period ended 2025-11-30 | $224,691,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-08 |
| Q3 FY2026Period ended 2026-02-28 | $211,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-09 |
| Q4 FY2026Period ended 2026-05-31 | $225,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $870,380,000 |
Current P/S: $2,669,005,440 market capitalization ÷ $870,380,000 TTM revenue = 3.07x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:10:21.000Z. Latest revenue period ended 2026-05-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-05-31): $225.30M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:13:58.639Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-05-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-05-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-05-31 · USD | FY20222022-05-31 · USD | FY20232023-05-31 · USD | FY20242024-05-31 · USD | FY20252025-05-31 · USD | FY20262026-05-31 · USD |
|---|---|---|---|---|---|---|
| Product | $376M | $425M | $715M | $822M | $797M | $768M |
| Service | $92M | $102M | $107M | $102M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-05-31 · USD | FY20222022-05-31 · USD | FY20232023-05-31 · USD | FY20242024-05-31 · USD | FY20252025-05-31 · USD | FY20262026-05-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $183M | $209M | $398M | $459M | $449M | $445M |
| UNITED STATES | $285M | $318M | $424M | $465M |
$870.38M
$870.38 Million
(2.71%)
vs. $894.62M a year ago (TTM)
+13.19%
5 Year compound annual growth rate
1 Year
(2.71%)
3 Year
(1.96%)
5 Year
+13.19%
10 Year
+10.48%
15 Year
+11.39%
20 Year
+13.24%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $870.40M | ($24.26M) | (2.71%) |
| 2025 | $894.66M | ($29.56M) | (3.20%) |
| 2024 | $924.22M | +$101.78M | +12.37% |
| 2023 | $822.45M | +$295.29M | +56.01% |
| 2022 | $527.16M | +$58.70M | +12.53% |
| 2021 |
TTM Growth
(2.71%)
3-Year CAGR
(1.96%)
5-Year CAGR
+13.19%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:13:58.639Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $97M |
| $102M |
| $425M |
| $468.46M |
| +$50.29M |
| +12.03% |
| 2020 | $418.17M | +$3.98M | +0.96% |
| 2019 | $414.19M | +$16.26M | +4.09% |
| 2018 | $397.93M | +$39.65M | +11.07% |
| 2017 | $358.28M | +$37.00M | +11.52% |
